GS
CRL icon

GAM Systematic’s Charles River Laboratories CRL Stock Holding History

GAM Systematic’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.55M Buy
14,316
+8,713
+156% +$895K 0.22% 171
2017
Q2 		$567K Buy
5,603
+460
+9% +$42.3K 0.08% 391
2017
Q1 		$463K Sell
5,143
-1,170
-19% -$99.4K 0.09% 378
2016
Q4 		$481K Sell
6,313
-1,890
-23% -$144K 0.11% 330
2016
Q3 		$684K Sell
8,203
-335
-4% -$28.1K 0.14% 294
2016
Q2 		$704K Sell
8,538
-4,417
-34% -$364K 0.17% 241
2016
Q1 		$984K Buy
12,955
+2,365
+22% +$175K 0.26% 137
2015
Q4 		$851K Sell
10,590
-12,559
-54% -$906K 0.24% 155
2015
Q3 		$1.47M Buy
+23,149
New +$1.66M 0.34% 61

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAM Systematic's CRL Position: Q3 2017 in Review

GAM Systematic increased its Charles River Laboratories (CRL) stake by 156% in Q3 2017, buying an estimated $895K and bringing the position to 14,316 shares worth $1.55M. The position accounts for 0.22% of the portfolio, ranked #171.

GAM Systematic first reported a position in CRL in Q3 2015 and has held it in 9 quarters since. 336 funds tracked by Wall St. Rank hold CRL as of Q3 2017.

  • GAM Systematic held 14,316 shares of Charles River Laboratories worth $1.55M as of Q3 2017.
  • GAM Systematic bought 8,713 Charles River Laboratories shares in Q3 2017, an estimated $895K.
  • Charles River Laboratories made up 0.22% of GAM Systematic's portfolio in Q3 2017, its #171 holding.
  • GAM Systematic first reported a position in Charles River Laboratories in Q3 2015 and has held it in 9 quarters since.
  • 336 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.